Table 2.
Total | |
---|---|
N | 3705 |
IV rt-PA (%) | 1346/3572 (37.7) |
EVT procedures (%) | (n = 3676) |
Stand-alone IAT | 359 (9.8) |
Stand-alone PTA/BCD | 332 (9.0) |
Stand-alone thrombectomy using the Merci retriever | 420 (11.4) |
Stand-alone thromboaspiration using the Penumbra catheter | 783 (21.3) |
Stand-alone thrombectomy using other than the Merci retriever | 236 (6.4) |
Stand-alone stenting | 141 (3.8) |
Other single procedures | 102 (2.8) |
Any procedural combinations | 1303 (35.4) |
Any combination including IAT | 884 (24.0) |
Any combination including PTA/BCD | 966 (26.3) |
Any combination including the Merci retriever | 888 (24.2) |
Any combination including the Penumbra catheter | 1452 (39.5) |
Any combination including thrombectomy devices other than the Merci retriever | 377 (10.3) |
Any combination including stenting | 426 (11.6) |
Successful reperfusion (%) | 2166/3657 (59.2) |
TICI 3 | 1001 (27.4) |
Procedure-related intracranial hemorrhagic complications | 353/3692 (9.6) |
Clinical outcome at 30 days (%) | (n = 3608) |
Favorable | 1100 (30.5) |
Death | 402 (11.1) |
EVT: endovascular therapy, IAT: intra-arterial thrombolysis, IV rt-PA: intravenous recombinant tissue-plasminogen activator, PTA/BCD: percutaneous transluminal angioplasty/balloon clot disruption, TICI: Thrombolysis in Cerebral Infarction.